Tenet Healthcare Corp
NYSE:THC

Watchlist Manager
Tenet Healthcare Corp Logo
Tenet Healthcare Corp
NYSE:THC
Watchlist
Price: 227.7 USD -0.17%
Market Cap: $20B

Tenet Healthcare Corp
Investor Relations

In the bustling realm of healthcare, Tenet Healthcare Corporation stands as a dynamic force, intertwining patient care with resilient business strategies. Based in Dallas, Tenet has carved out a significant niche in the healthcare industry by operating an extensive network of facilities across the United States. This sprawling empire includes hospitals, surgical centers, and outpatient facilities, all underpinned by its commitment to quality care. Tenet's operations are driven by a keen understanding of community health needs, offering specialized services through its brands, including the renowned Conifer Health Solutions and United Surgical Partners International (USPI). At its core, Tenet's business model is shaped by the drive to enhance accessibility, efficacy, and efficiency in healthcare delivery, balancing patient needs with sound economic strategies.

Financially, Tenet Healthcare generates revenue through a blend of patient services, surgical operations, and management consulting via its subsidiaries. By aligning its hospital network with the ever-growing demand for outpatient surgery services, particularly through USPI, the company taps into the profitable sphere of ambulatory care. Conifer Health Solutions, on the other hand, provides innovative revenue cycle and value-based care services, fostering sustainable financial health for healthcare providers nationwide. This multifaceted approach allows Tenet to continuously scale its operations while adapting to the evolving landscape of healthcare regulations and consumer expectations. Through strategic acquisitions and partnerships, Tenet ensures its expansion is both sustainable and aligned with emerging healthcare trends, underpinning its robustness in an ever-competitive field.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2025
Call Date
Feb 11, 2026
AI Summary
Q4 2025

Strong 2025 Performance: Tenet reported 2025 net operating revenues of $21.3 billion and adjusted EBITDA of $4.57 billion, up 14% over the prior year, with margins improving over 200 basis points.

Guidance Above Expectations: Both Q4 and full year results were above expectations, with full year adjusted EBITDA nearly $500 million higher than the midpoint of initial guidance.

USPI and Hospitals Growth: USPI adjusted EBITDA grew 12% to $2.03 billion and hospitals adjusted EBITDA grew 16% to $2.54 billion in 2025, with strong same-store revenue and volume growth, especially in high-acuity areas.

Capital Deployment: The company repurchased 22% of shares since late 2022, invested heavily in M&A and de novo development, and has significant cash on hand with no near-term debt maturities.

2026 Guidance: 2026 adjusted EBITDA expected in the range of $4.485 billion to $4.785 billion; revenue guidance is $21.5 billion to $22.3 billion. Guidance incorporates headwinds from the expiration of enhanced premium tax credits.

Structural Cost Management: Tenet is implementing more structural, technology-driven approaches to cost management aimed at sustaining margin improvements over the long term.

Headwinds and Assumptions: Guidance assumes a 20% reduction in exchange enrollment, a $250 million EBITDA headwind from tax credit expirations, and conservative assumptions about Medicaid supplemental payments.

Shareholder Focus: Management remains focused on driving organic and M&A growth, continued share repurchases, and maintaining financial flexibility.

Key Financials
Net Operating Revenues
$21.3 billion
Consolidated Adjusted EBITDA
$4.566 billion
Adjusted EBITDA Margin
21.4%
Fourth Quarter Net Operating Revenues
$5.5 billion
Fourth Quarter Consolidated Adjusted EBITDA
$1.183 billion
USPI Adjusted EBITDA
$2.03 billion
USPI Adjusted EBITDA Margin
40.5%
Hospital Adjusted EBITDA
$2.54 billion
Consolidated Salary, Wages and Benefits (as % of Net Revenues)
40.2%
Contract Labor Expense (as % of SW&B)
2.1%
Free Cash Flow (Q4 2025)
$367 million
Free Cash Flow (Full Year 2025)
$2.53 billion
Cash on Hand (12/31/2025)
$2.88 billion
Leverage Ratio
2.25x EBITDA
Leverage Ratio (EBITDA less NCI)
2.85x
Share Repurchases (Q4 2025)
943,000 shares for $198 million
Share Repurchases (2025)
8.8 million shares for $1.386 billion
Free Cash Flow Guidance (2026)
$2.5 billion to $2.8 billion
Adjusted Free Cash Flow after NCI (2026 Guidance)
$1.6 billion to $1.83 billion
Capital Expenditures Guidance (2026)
$700 million to $800 million
Supplemental Medicaid Payments (2025)
$1.34 billion
DPP Received (Q4 2025)
$315 million
Earnings Call Recording
Other Earnings Calls

Management

Dr. Saumya Sutaria M.D.
Chairman & CEO
No Bio Available
Ms. Paola M. Arbour
Executive VP & Chief Information Officer
No Bio Available
Mr. Thomas W. Arnst
EVP, Chief Administrative Officer, Chief Risk Officer, General Counsel & Corporate Secretary
No Bio Available
Ms. Lisa Y. Foo
Executive Vice President of Commercial Operations
No Bio Available
Mr. Sun K. Park
Executive VP & CFO
No Bio Available
Mr. William McDowell III
Vice President of Investor Relations
No Bio Available
Ms. Jana Durfee
Senior VP & Chief Compliance Officer
No Bio Available
Mr. Michael T. Maloney
Executive Vice President of Corporate Development
No Bio Available
Mr. Clint Hailey
Chief Managed Care Officer & Senior VP
No Bio Available
Ms. Liz Johnson
Chief Applied Clinical Informatics Officer
No Bio Available

Contacts

Address
TEXAS
Dallas
14201 Dallas Parkway
Contacts
+14698932200.0
www.tenethealth.com